Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZYG11BL Inhibitors

ZYG11BL inhibitors are a chemical class that target the ZYG11B-like (ZYG11BL) protein, a homolog of the ZYG11 family involved in protein ubiquitination. ZYG11BL belongs to the ubiquitin-proteasome system (UPS), a complex cellular mechanism responsible for degrading and recycling proteins, ensuring proper cellular function and regulation. The ZYG11 family, including ZYG11BL, acts as substrate adaptors that help recognize and tag certain proteins for degradation. Inhibitors of ZYG11BL are designed to interfere with this recognition and tagging process, potentially leading to altered protein degradation patterns within cells. The inhibition of ZYG11BL can have significant effects on cellular homeostasis, influencing protein turnover, signaling pathways, and cell cycle progression.

These inhibitors can be useful tools in studying the functional dynamics of the ubiquitin-proteasome system, particularly in the context of understanding how specific proteins are targeted for degradation. By inhibiting ZYG11BL, researchers can gain insights into the biological roles of proteins that rely on this degradation pathway, which can have widespread effects on cellular processes such as metabolism, growth, and stress responses. Furthermore, ZYG11BL inhibitors can help elucidate the complex interactions between the components of the UPS and how they are regulated at different stages of protein life cycles. These inhibitors offer a valuable approach for probing protein homeostasis mechanisms, which are critical for maintaining cellular integrity in various biological systems.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that can hinder protein degradation pathways in which ZYG11BL may be involved.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that can alter signaling pathways and may indirectly affect ZYG11BL-involved processes.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

An mTOR inhibitor that can disrupt cellular growth pathways potentially linked to ZYG11BL activity.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that can inhibit calcineurin, possibly affecting ZYG11BL through altered signaling pathways.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor that can modify inflammatory response pathways in which ZYG11BL may play a role.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

An inhibitor of MEK1/2, which can affect MAPK/ERK pathways and thus potentially ZYG11BL's function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

An inhibitor of JNK, which can alter stress response pathways possibly involving ZYG11BL.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

A proteasome inhibitor that can affect protein degradation systems, potentially impacting ZYG11BL.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An inhibitor of MEK, which can disrupt MAPK/ERK signaling pathways, possibly affecting ZYG11BL.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A PI3K inhibitor that can impact various signaling pathways and potentially modulate ZYG11BL activity.